DeepMed Research

RUTGERS, THE STATE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Molecular Markers and Genetic Markers in Patients Undergoing Radiation Therapy for Cancer

Withdrawn

Conditions: Hematopoietic/Lymphoid Cancer
Unspecified Adult Solid Tumor, Protocol Specific
Unspecified Childhood Solid Tumor, Protocol Specific

First Posted Date: 2009-05-12

Last Posted Date: 2015-05-29

Lead Sponsor: Rutgers, The State University of New Jersey

Registration Number: NCT00899808

Locations: 🇺🇸
Rutgers Cancer Institute of New Jersey - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States

Treatment Decision Making Between Oncologists and Women With Newly Diagnosed Breast Cancer and Their Healthy Companions

Terminated

Conditions: Breast Cancer

First Posted Date: 2009-05-01

Last Posted Date: 2015-11-09

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 77

Registration Number: NCT00891969

Locations: 🇺🇸
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States

Intensity-Modulated Radiation Therapy and Gemcitabine in Treating Patients With Locally Advanced Pancreatic Cancer

Phase 1

Terminated

Conditions: Pancreatic Cancer

Interventions: Drug: gemcitabine hydrochloride
Radiation: intensity-modulated radiation therapy

First Posted Date: 2009-04-09

Last Posted Date: 2014-05-05

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 8

Registration Number: NCT00878657

Locations: 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

Determine the Effect of Intraocular Pressure (IOP), Optic Nerve Imaging, Venous Congestion in Volunteers Prone Position 5 Hours

Completed

Conditions: Blindness

First Posted Date: 2009-04-03

Last Posted Date: 2016-10-14

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 10

Registration Number: NCT00875043

Locations: 🇺🇸
UMDNJ/University Hospital, Newark, New Jersey, United States

Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Phase 2

Completed

Conditions: Melanoma (Skin)

Interventions: Drug: riluzole

First Posted Date: 2009-03-23

Last Posted Date: 2024-01-19

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 13

Registration Number: NCT00866840

Locations: 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

Comparison of Enteral Versus Parenteral Feeding in Healthy Human Subjects

Phase 1

Completed

Conditions: Healthy

Interventions: Dietary Supplement: Enteral Intermittent
Dietary Supplement: Enteral Continuous
Dietary Supplement: Parenteral Continuous

First Posted Date: 2009-03-05

Last Posted Date: 2015-05-22

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 12

Registration Number: NCT00856219

Locations: 🇺🇸
Rutgers-RWJMS, New Brunswick, New Jersey, United States

Sunitinib and Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer

Phase 2

Terminated

Conditions: Kidney Cancer

Interventions: Biological: therapeutic allogeneic lymphocytes
Drug: sunitinib malate

First Posted Date: 2009-03-02

Last Posted Date: 2021-04-27

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 10

Registration Number: NCT00853125

Locations: 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

Inflammation and the Host Response to Injury (In Healthy Volunteers)

Phase 1

Completed

Conditions: Immune System

Interventions: Biological: Endotoxin, Lipopolysaccharide, LPS

First Posted Date: 2009-01-12

Last Posted Date: 2014-05-21

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 116

Registration Number: NCT00820989

Locations: 🇺🇸
Rutgers-RWJMS, New Brunswick, New Jersey, United States

Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers

Withdrawn

Conditions: Unspecified Adult Solid Tumor, Protocol Specific
Brain and Central Nervous System Tumors
Depression
Lymphoma
Myelodysplastic Syndromes
Psychosocial Effects of Cancer and Its Treatment
Chronic Myeloproliferative Disorders
Leukemia
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic/Myeloproliferative Neoplasms

First Posted Date: 2008-10-10

Last Posted Date: 2015-05-29

Lead Sponsor: Rutgers, The State University of New Jersey

Registration Number: NCT00770419

Medical Nutrition Therapy or Standard Care in Treating Patients With Lung Cancer, Pancreatic Cancer, or Stage III or Stage IV Prostate Cancer

Not Applicable

Terminated

Conditions: Lung Cancer
Pancreatic Cancer
Malnutrition
Weight Changes
Prostate Cancer

Interventions: Behavioral: Medical nutrition therapy
Behavioral: Standard Care

First Posted Date: 2008-10-09

Last Posted Date: 2023-10-03

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 8

Registration Number: NCT00769652

Locations: 🇺🇸
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy